Active Ingredient(s): Emapalumab-lzsg
FDA Approved: * November 20, 2018
Pharm Company: * NOVIMMUNE S.A.
Category: Genetic Disorders

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Gamifant Overview

Emapalumab, marketed under the trade name Gamifant, is an anti-interferon-gamma (IFNγ) antibody used for the treatment of hemophagocytic lymphohistiocytosis (HLH),[3] which currently has no cure.[4] Contents 1 Adverse effects 2 Pharmacology 2.1 Mechanism of action 2.2 Pharmacokinetics 3 Society and culture 4 Research 5 References 6 External links Adverse effects In the clinical trials that lead to emapalumab's FDA approval, the most commonly repo...

Read more Gamifant Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Gamifant Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 10mg/2ml, 50mg/10ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Gamifant: (5 results)

Sorted by National Drug Code
  • 66658-501 Gamifant 10 mg/2ml Intravenous Injection by Swedish Orphan Biovitrum Ab (Publ)
  • 66658-505 Gamifant 50 mg/10ml Intravenous Injection by Swedish Orphan Biovitrum Ab (Publ)
  • 66658-510 Gamifant 100 mg/20ml Intravenous Injection by Swedish Orphan Biovitrum Ab (Publ)
  • 72171-501 Gamifant 10 mg/2ml Intravenous Injection by Novimmune Sa
  • 72171-505 Gamifant 50 mg/10ml Intravenous Injection by Novimmune Sa

Other drugs which contain Emapalumab-lzsg or a similar ingredient: (1 result)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 21 October 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA